HIV-1 INHIBITOR OF SITE-SPECIFIC COVALENTLY CROSS-LINKED NATURAL N-TERMINAL PEPTIDE

摘要

Provided is an inhibitor of human immunodeficiency virus type 1. The inhibitor is a site-specific covalently cross-linked N-terminal peptide compound, derivative, stereoisomer or salt having physiological toxicity thereof. Also provided are a pharmaceutical composition of the compound and use of the compound in preparing related medicine for preventing and/or treating a human immunodeficiency virus infection.